Tommaso Rossi1,2, Danilo Iannetta3, Vito Romano4, Carlo Carlevale5, Matteo Forlini6, Serena Telani7, Aurelio Imburgia6, Alessandro Mularoni6, Luigi Fontana3, Guido Ripandelli8. 1. IRCCS Ospedale Policlinico San Martino, Genoa, Italy. tommaso.rossi@usa.net. 2. IRCCS Policlinico San Martino - UOC Oculistica, Largo Rosanna Benzi 2, 16100, Genoa, Italy. tommaso.rossi@usa.net. 3. Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. 4. St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK. 5. Karol Wojtyla Hospital, Rome, Italy. 6. Department of Ophthalmology, San Marino Hospital, San Marino, Republic of San Marino. 7. IRCCS Ospedale Policlinico San Martino, Genoa, Italy. 8. IRCCS Fondazione G.B. Bietti ONLUS, Rome, Italy.
Abstract
PURPOSE: To report a retrospective series of patients implanted with a novel hydrophilic acrylic single-piece intraocular lens (IOL) designed for sutureless scleral fixation (FIL-SSF Carlevale lens, Soleko, Italy) injectable through a 2.2-mm incision. METHODS: Seventy-eight patients with minimum 6-month follow-up were divided into 6 groups: dropped nucleus, luxated IOL, trauma, aphakia, IOL exchange, and Marfan's syndrome. Surgery included peritomy and scleral flap creation at 3 and 9 o'clock position. The IOL was then injected and grasped with 25G forceps through a hole created 2 mm posterior to the limbus underneath the sculped scleral flap. RESULTS: The study included 78 patients (mean age 71.9 ± 12.6 years) and average follow-up 10.2 ± 4.2 months. Average surgery duration was 69.4 ± 26.1 min and vision significantly improved from 0.86 ± 0.56 logMAR to 0.38 ± 0.42 logMAR at 6 months post-operative (p < 0.001). Intraoperative complications included corneal edema, retinal tears, and vitreous bleeding each in 2/78 patients (2.5%); 1/78 (1.3%) localized retinal detachment and 1/78 (1.3%) rupture of one T-shaped IOL harpoon. Post-operative complications included 4/78 (5.1%) cystoid macular edemas, 2/78 retinal tears, 2/78 retinal detachments, 2/78 developed ocular hypertension, and 1/78 corneal decompensation requiring DSAEK. CONCLUSION: The Carlevale lens is designed for sutureless intrascleral fixation and can be successfully used in a variety of indications including difficult trauma cases with good rehabilitation. An implant requires experience and delicate manipulation.
PURPOSE: To report a retrospective series of patients implanted with a novel hydrophilic acrylic single-piece intraocular lens (IOL) designed for sutureless scleral fixation (FIL-SSF Carlevale lens, Soleko, Italy) injectable through a 2.2-mm incision. METHODS: Seventy-eight patients with minimum 6-month follow-up were divided into 6 groups: dropped nucleus, luxated IOL, trauma, aphakia, IOL exchange, and Marfan's syndrome. Surgery included peritomy and scleral flap creation at 3 and 9 o'clock position. The IOL was then injected and grasped with 25G forceps through a hole created 2 mm posterior to the limbus underneath the sculped scleral flap. RESULTS: The study included 78 patients (mean age 71.9 ± 12.6 years) and average follow-up 10.2 ± 4.2 months. Average surgery duration was 69.4 ± 26.1 min and vision significantly improved from 0.86 ± 0.56 logMAR to 0.38 ± 0.42 logMAR at 6 months post-operative (p < 0.001). Intraoperative complications included corneal edema, retinal tears, and vitreous bleeding each in 2/78 patients (2.5%); 1/78 (1.3%) localized retinal detachment and 1/78 (1.3%) rupture of one T-shaped IOL harpoon. Post-operative complications included 4/78 (5.1%) cystoid macular edemas, 2/78 retinal tears, 2/78 retinal detachments, 2/78 developed ocular hypertension, and 1/78 corneal decompensation requiring DSAEK. CONCLUSION: The Carlevale lens is designed for sutureless intrascleral fixation and can be successfully used in a variety of indications including difficult trauma cases with good rehabilitation. An implant requires experience and delicate manipulation.
Entities:
Keywords:
Aphakia; Intraocular lens; Pars plana vitrectomy; Scleral fixation; Sutureless intraocular lens
Authors: Tomasz K Wilczyński; Alfred Niewiem; Rafał Leszczyński; Katarzyna Michalska-Małecka Journal: Int J Environ Res Public Health Date: 2021-04-25 Impact factor: 3.390